Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
ID: 353975Type: Forecasted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$0 - $500K

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted May 3, 2024 12:00 AM
  4. 4
    Due Not available
Description

The Centers for Disease Control and Prevention - ERA is seeking investigator-initiated research to identify and evaluate potential risk factors for Amyotrophic Lateral Sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and loss of motor function. The research should focus on factors related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. The funding options include supporting existing evidence-based research, novel exploratory research, and underrepresented populations such as racial and ethnic minorities and military veterans. The total program funding is $7,500,000, with an expected number of 8 awards. Small businesses are eligible to apply. The application deadline is November 1, 2024, and the estimated award date is September 30, 2025. For more information, contact Candis M. Hunter, PhD, MSPH, REHS at 770-488-1347 or ncipc_erpo@cdc.gov.

Point(s) of Contact
Candis M. Hunter, PhD, MSPH, REHS
(770) 488-1347
ncipc_erpo@cdc.gov
Files
No associated files provided.
Similar Opportunities
Epilepsy Incidence Among Children in the United States
Centers for Disease Control and Prevention - ERA
The Centers for Disease Control and Prevention - ERA is forecasting a federal grant opportunity titled "Epilepsy Incidence Among Children in the United States". This cooperative agreement aims to conduct a comprehensive study on epilepsy incidence among children in the United States. The study will estimate epilepsy incidence rates, identify risk factors associated with developing epilepsy, and examine potential disparities in incidence rates based on demographic, geographical, and social determinants of health (SDOH) factors. The target population for this study is U.S. children aged 0 - 17 years, and the study should include a nationally representative sample of age, sex, race/ethnicity, and social strata. The applicant is expected to conduct a retrospective study using public/commercial administrative and/or claims data, electronic health records, or survey data. The dataset(s) used should have sufficient sample sizes relative to risk factors, allowing incidence rates to be stratified by these factors. The estimated total program funding for this grant opportunity is $1,600,000, with an award ceiling of $500,000. The deadline for electronically submitted applications is January 23, 2025, and the estimated award date is August 25, 2025. For more information, you can visit the following links: [Link 1](https://www.nap.edu/read/13379/chapter/1) and [Link 2](https://pubmed.ncbi.nlm.nih.gov/32451250/). For any inquiries, you can contact Alison Amoroso, the Scientific Program Official, at aamoroso@cdc.gov or 470-395-2521.